ACEP clinical policies: Difference between revisions
Amyamamoto (talk | contribs) No edit summary |
Amyamamoto (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
* '''Level C:''' Other strategies for patient management based on Class III studies, or in absence of any adequate, published literature and based on panel consensus. | * '''Level C:''' Other strategies for patient management based on Class III studies, or in absence of any adequate, published literature and based on panel consensus. | ||
== tPA for Acute Ischemic Stroke ( | * ''Inclusion:'' | ||
* ''Exclusion:'' | |||
* '''Level A:''' | |||
* '''Level B:''' | |||
* '''Level C:''' | |||
* ''Source:'' | |||
== Procedural sedation (2013) | |||
* ''Inclusion:'' Patients of all age with emergent/urgent condition that require pain +/or anxiety management to accomplish interventional or diagnostic procedure and for high-risk patients (cardiopulm d/o, multiple/head trauma, CNS depressant) w understanding that these patients are at increased risk of complications from procedural sedation and analgesia. | |||
* ''Exclusion:'' Patients receiving inhalational anesthetics, analgesia for pain control without sedatives, sedation solely for anxiolysis and behavioral emergencies, or intubated patients, | |||
* '''Level A:''' | |||
** Ketamine safe for children. Propofol safe for children and adults for sedation in analgesia in ED. | |||
* '''Level B:''' | |||
** Do not delay procedural sedation in adults or pediatrics in the ED based on fasting time. Preprocedural fasting for any duration has not demonstrated a reduction in risk of emesis or aspiration | |||
** Capnography may be used as adjunct to pulse ox and clinical assessment to detect hypoventilation and apnea earlier than pulse ox +/or clinical assessment alone | |||
** Etomidate safe to adults. Combination of propofol and ketamine safe for children and adults. | |||
* '''Level C:''' | |||
** During procedural sedation and analgesia, a nurse or other qualified individual should be present for continuous monitoring, in addition to the provider performing procedure. Physicians who are working or consulting in ED should coordinate procedures. | |||
** Ketamine safe for adults. Alfentanil safe for adults. Etomidate safe for children. | |||
* ''Source:'' Clinical policy: Procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2014;63:247-258. | |||
== tPA for Acute Ischemic Stroke (2012)== | |||
* ''Inclusion:'' Adult patients presenting to ED with acute ischemic stroke | * ''Inclusion:'' Adult patients presenting to ED with acute ischemic stroke | ||
* ''Exclusion:'' | * ''Exclusion:'' Children < 18 years | ||
* '''Level A:''' | * '''Level A:''' | ||
** Offer IV tPA to acute ischemic stroke patients who meet NINDS inclusion/exclusion criteria and can be treated within 3 hours after symptom onset. | ** Offer IV tPA to acute ischemic stroke patients who meet NINDS inclusion/exclusion criteria and can be treated within 3 hours after symptom onset. | ||
| Line 13: | Line 34: | ||
* ''Source:'' Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke int he emergency department. Ann Emerg Med. 2013;61:225-243. | * ''Source:'' Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke int he emergency department. Ann Emerg Med. 2013;61:225-243. | ||
==Neuroimaging and decision making in TBI ( | |||
==Neuroimaging and decision making in TBI (2008)== | |||
* ''Inclusion:'' | * ''Inclusion:'' | ||
** Nonpenetrating trauma to the head | ** Nonpenetrating trauma to the head | ||
| Line 72: | Line 76: | ||
* No specific recommendation for use of head MRI in patient with mild TBI | * No specific recommendation for use of head MRI in patient with mild TBI | ||
* ''Source:'' Clinical policy: Neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann Emerg Med. 2008;52:714-748. | * ''Source:'' Clinical policy: Neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann Emerg Med. 2008;52:714-748. | ||
== Syncope (2007)== | |||
* ''Inclusion:'' Adult | |||
* ''Exclusion:'' Children or for patients whom episode of syncope is thought to be secondary to another disease process | |||
* '''Level A:''' | |||
** Hx and PE c/w heart failure help identify patients at high risk for an adverse outcome. | |||
** Standard 12-lead EKG | |||
* '''Level B:''' | |||
** High risk of AE: Older age, structural heart disease, h/o CAD | |||
** Low risk of AE: younger, nonexertional, w/o h/o or signs of CVD or family hx of sudden death and w/o comorbidities | |||
** Admit patients with syncope and evidence of heart failure or structural heart disease | |||
** Admit patients with syncope and other factors that lead to stratification as high-risk for adverse outcomes. | |||
*** Older age and associated comorbidities | |||
*** Abnormal EKG (Acute ischemia, dysrhythmia, or significant conduction abnormalities) | |||
*** Hct < 30 (if obtained) | |||
*** Hx or presence of heart failure, CAD< or structural heart disease | |||
* '''Level C:''' | |||
** Lab testing and advanced investigative testing such as echo or cranial CT need not be routinely performed unless guided by specific findings in the Hx and PE. 2 | |||
* ''Source:'' Clinical Policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope. Ann Emerg Med. 2007;49:431-444. | |||
Revision as of 01:24, 26 December 2014
Guidelines for ACEP Clinical Policy
- Level A: Generally accepted principles for patient management that reflect high degree of clinical certainty.
- Level B: Recommendations for patient management that may identify a particular strategy or range of management strategies that reflect moderate clinical certainty.
- Level C: Other strategies for patient management based on Class III studies, or in absence of any adequate, published literature and based on panel consensus.
- Inclusion:
- Exclusion:
- Level A:
- Level B:
- Level C:
- Source:
== Procedural sedation (2013)
- Inclusion: Patients of all age with emergent/urgent condition that require pain +/or anxiety management to accomplish interventional or diagnostic procedure and for high-risk patients (cardiopulm d/o, multiple/head trauma, CNS depressant) w understanding that these patients are at increased risk of complications from procedural sedation and analgesia.
- Exclusion: Patients receiving inhalational anesthetics, analgesia for pain control without sedatives, sedation solely for anxiolysis and behavioral emergencies, or intubated patients,
- Level A:
- Ketamine safe for children. Propofol safe for children and adults for sedation in analgesia in ED.
- Level B:
- Do not delay procedural sedation in adults or pediatrics in the ED based on fasting time. Preprocedural fasting for any duration has not demonstrated a reduction in risk of emesis or aspiration
- Capnography may be used as adjunct to pulse ox and clinical assessment to detect hypoventilation and apnea earlier than pulse ox +/or clinical assessment alone
- Etomidate safe to adults. Combination of propofol and ketamine safe for children and adults.
- Level C:
- During procedural sedation and analgesia, a nurse or other qualified individual should be present for continuous monitoring, in addition to the provider performing procedure. Physicians who are working or consulting in ED should coordinate procedures.
- Ketamine safe for adults. Alfentanil safe for adults. Etomidate safe for children.
- Source: Clinical policy: Procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2014;63:247-258.
tPA for Acute Ischemic Stroke (2012)
- Inclusion: Adult patients presenting to ED with acute ischemic stroke
- Exclusion: Children < 18 years
- Level A:
- Offer IV tPA to acute ischemic stroke patients who meet NINDS inclusion/exclusion criteria and can be treated within 3 hours after symptom onset.
- Level B:
- To consider IV tPA to acute ischemic stroke patients who meet ECASS III inclusion/exclusion criteria and can be treated between 3 to 4.5 hours after symptom onset.
- Source: Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke int he emergency department. Ann Emerg Med. 2013;61:225-243.
Neuroimaging and decision making in TBI (2008)
- Inclusion:
- Nonpenetrating trauma to the head
- Presentation to ED within 24 hours of injury
- GCS 14 or 15 on initial evaluation in ED
- Age ≥ 16
- Exclusion:
- Penetrating trauma
- Patients with multi-system trauma
- GCS < 14 on initial evaluation in the ED
- Age < 16
- Level A:
- A noncontrast head CT indicate in head trauma patients with LOC or posttraumatic amnesia only if ≥ 1 of following is present:
- Headache
- Vomiting
- Age> 60
- Drug or alcohol intoxication
- Deficits in short-term memory
- Physical evidence of trauma above the clavicle
- Posttraumatic seizure
- GCS < 15
- Focal neurological deficit
- Coagulopathy
- A noncontrast head CT indicate in head trauma patients with LOC or posttraumatic amnesia only if ≥ 1 of following is present:
- Level B:
- A noncontrast head CT should be considered in head trauma patients with no LOC or porttraumatic amnesia if there is:
- Focal neurological deficit
- Vomiting
- Severe headache
- Age ≥ 65
- Physical signs of basilar skull fracture
- GCS < 15
- Coagulopathy
- Dangerous mechanism of injury
- Patients with an isolated TBI who have a negative head CT scan result are at a minimal risk for developing an intracranial lesion and therefore may be safely discharged from the ED.
- Skull film radiographs are not recommended in mild TBI. Although presence of skull fracture increases the likelihood of intracranial lesion, its sensitivity is not sufficient to be a useful screening test. Negative findings on skull films may mislead clinicians.
- A noncontrast head CT should be considered in head trauma patients with no LOC or porttraumatic amnesia if there is:
- Level C:
- In mild TBI patient with significant extracranial injuries and a serum S-100B level less than 0.5ℳg/L measured within 4 hours if injury, consideration can be given to not performing a CT.
- Mild TBI patients discharged from the E should be informed abut postconcussive symptoms.
- No specific recommendation for use of head MRI in patient with mild TBI
- Source: Clinical policy: Neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann Emerg Med. 2008;52:714-748.
Syncope (2007)
- Inclusion: Adult
- Exclusion: Children or for patients whom episode of syncope is thought to be secondary to another disease process
- Level A:
- Hx and PE c/w heart failure help identify patients at high risk for an adverse outcome.
- Standard 12-lead EKG
- Level B:
- High risk of AE: Older age, structural heart disease, h/o CAD
- Low risk of AE: younger, nonexertional, w/o h/o or signs of CVD or family hx of sudden death and w/o comorbidities
- Admit patients with syncope and evidence of heart failure or structural heart disease
- Admit patients with syncope and other factors that lead to stratification as high-risk for adverse outcomes.
- Older age and associated comorbidities
- Abnormal EKG (Acute ischemia, dysrhythmia, or significant conduction abnormalities)
- Hct < 30 (if obtained)
- Hx or presence of heart failure, CAD< or structural heart disease
- Level C:
- Lab testing and advanced investigative testing such as echo or cranial CT need not be routinely performed unless guided by specific findings in the Hx and PE. 2
- Source: Clinical Policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope. Ann Emerg Med. 2007;49:431-444.
